Neuroprotection by cyclosporin A following transient brain ischemia correlates with the inhibition of the early efflux of cytochrome C to cytoplasm

Molecular Brain Research

Volumn 121, Issue 1-2, 2004, Pages 50-59

  Domañska Janik, Krystyna ^a   Buzañska, Leonora ^a   Dłuzniewska, Joanna ^a   Kozłowska, Hanna ^a   Sarnowska, Anna ^a   Zabłocka, Barbara ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Brain ischemia; Cytochrome C translocation; Mitochondria; Neuroprotection; Route of drug administration

Indexed keywords

CYCLOSPORIN A; CYTOCHROME C; SANDIMUNE; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN REGION; CAROTID ARTERY; CELL COUNT; CELL PROTECTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE MODEL; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; DRUG POTENCY; EMBRYO; GERBIL; HIPPOCAMPUS; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MALE; MITOCHONDRION; NERVE CELL; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; REPERFUSION; TRANSIENT ISCHEMIC ATTACK;

GERBILLINAE;

EID: 1242351328     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.11.006     Document Type: Article

References (31)

1. Araya R., Uchara T., Nomura Y. Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett. 439:1998;168-172.
2. Bronisz A., Gajkowska B., Domañska-Janik K. PKC and Raf-1 inhibition-related apoptotic signalling in N2a cells. J. Neurochem. 81(6):2002;1176-1184.
3. Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J. Physiol. 529:2000;11-21.
4. Domañska-Janik K., Zablocka B. Protein kinase C as an early and sensitive marker of ischemia- induced progressive damage in gerbil hippocampus. Mol. Chem. Neuropathol. 20(2):1993;111-123.
5. Domañska-Janik K., Zalewska T. Effect of brain ischemia on protein kinase C. J. Neurochem. 58:1992;1432-1439.
6. Domañska-Janik K., Lazarewicz J., Noremberg K., Strosznajder J., Zalewska T. Metabolic disturbances of synaptosomes isolated from ischemic gerbil brain. Neurochem. Res. 10(5):1985;649-665.
7. Domañska-Janik K., Bong P., Bronisz-Kowalczyk A., Zajac H., Zablocka B. AP1 transcriptional factor activation and its relation to apoptosis of hippocampal CA1 pyramidal neurons after transient ischemia in gerbils. J. Neurosci. Res. 57:1999;840-846.
8. Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A.P., Wieloch T. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci. 18(5):1998;151-5159.
9. Friberg H., Connern C., Halestrap A., Wieloch T. Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability. J. Neurochem. 72:1999;2488-2497.
10. Gold B.G., Densmore V., Shou W., Matzuk M.M., Gordon H.S. Immunophilin FK 506-binding protein 52 (not FK 506-binding protein 12) mediates the neurotrophic action of FK 506. J. Pharmacol. Exp. Ther. 289:1999;1202-1210.
11. Hansson M.J., Persson T., Friberg H., Keep M.F., Rees A., Wieloch T., Elmer E. Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res. 960:2003;99-111.
12. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
13. Li P.-A., Howlett W., He P.Q., Miyashita H., Siddqui M., Shuaib A. Postischemic treatment with calpain inhibitor MDL-28. 170 ameliorates brain damage in gerbil model of global ischemia Neurosci. Lett. 247:1998;17-20.
14. Li P.-A., He Q.-P., Ouyang Y.-B., Liu C.-L., Hu B.-R., Siesjö B.K. Early release of cytochrome C and activation of caspase-3 in hyperglycemic rats subjected to transient forebrain ischemia. Brain Res. 896:2001;69-76.
15. Liu J., Farmer J.D. Jr., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
16. Matsumoto S., Isshiki A., Watanabe Y., Wieloch T. Restricted clinical efficiency of cyclosporin A on rat transient middle cerebral artery occlusion. Life Sci. 72:2002;591-600.
17. Neumar R.W., Meng F.H., Mills A.M., Xu A., Zhang C., Welsh F.A., Siman R. Calpain activity in the rat brain after transient forebrain ischemia. Exp. Neurol. 170:2001;27-35.
18. Ouyang Y.-B., Tan Y., Comb M., Liu C.-L., Martone M.E., Siesjo B.K., Hu B.-R. Survival- and death-promoting events after transient cerebral ischemia: phosphorylation of Akt, release of cytochrome c and activation of caspase-like proteases. J. Cereb. Blood Flow Metab. 19:1999;1126-1135.
19. Ryba M., Pastuszko M., Iwanska K., Bidziński J., Dziewiecki C. Cyclosporin A prevents neurological deterioration of patients with SAH - a preliminary report. Acta Neurochir. 112:1991;25-27. (Wien).
20. Sakata A., Tamai I., Kawazu K., Deguchi Y., Ohnishi T., Saheki A., Tsuji A. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem. Pharmacol. 48:1994;1989-1992.
21. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signalling through transcription factor NF-AT by interaction between calcineurin and Bcl2. Nature. 386:1997;728-731.
22. Shirai A., Naito M., Tatsuta J., Dong J., Hanaoka K., Mikami K., Oh-hara T., Tsurou T. Transport of cyclosporin A across the brain capillary cell monolayer by P-glycoprotein. Biochim. Biophys. Acta. 1222:1994;400-404.
23. Siesjö B.K., Katsura K.-I., Zhao Q., Folbergova J., Pahlmark K., Siesjö P. Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J. Neurotrauma. 12:1995;943-956.
24. Uchino H., Minamikawa-Tachino R., Kristian T., Perkins G., Narazaki M., Siesjö B.K., Shibasaki F. Differential neuroprotection by cyclosporin A and FK 506 following ischemia corresponds with different abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol. Dis. 10:2002;219-223.
25. Vachon P., Beaudry F., Merier J.-F., Ste-Marie L., Montgomery J. Cyclosporin A in blood and brain tissue following intra-carotid injection in normal and stroke-induced rats. Brain Res. 943:2002;1-8.
26. Wang H.G., Pathan N., Ethell I.M., Krajewski S., Yamaguchi Y., Shibasaki F., McKeon F., Bobo T., Franke T.F., Reed J.C. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 284:1999;339-343.
27. Yagita Y., Kitagawa K., Matsushita K., Taguchi A., Mabuchi T., Ohtsuki T., Yanagihara T., Matsumota M. Effect of immunosuppressant FK 506 on ischemia-induced degradation of hippocampal neurons in gerbils. Life Sci. 59:1996;1643-1650.
28. Yokota M., Tani E., Tsubuki S., Yamaura I., Nakagaki I., Hori S., Saido T.C. Calpain inhibitor entrapped in liposomes rescues ischemic neuronal damage. Brain Res. 819:1999;8-14.
29. Yoshimoto T., Siesjö B.K. Post treatment with immunosuppressant cyclosporin A in transient focal ischemia. Brain Res. 830:1999;283-291.
30. Zablocka B., Dluzniewska J., Zajac H., Domañska-Janik K. Opposite reaction of ERK and JNK in ischemia vulnerable and resistant regions of hippocampus: involvement of mitochondria. Mol. Brain Res. 110:2003;245-252.
31. Ziemka-Nalecz M., Zalewska T., Zajac H., Domañska-Janik K. Decrease of PKC precedes other cellular signs of calpain activation in area CA1 of the hippocampus after transient cerebral ischemia. Neurochem. Int. 42:2003;205-214.